Ronney Stadler, MD
Colon & Rectal Surgery · Irving, TXNPI 1356372098
Payments from drug & device makers
Across 53 payments — averaging $43.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Johnson & Johnson$642
- Pharmacosmos Therapeutics Inc.$115
- Medical Device Business Services, Inc.$112
- Stryker$100
- AbbVie$94
- plus $184 from 7 others
What the payments were for
- Speaking & faculty fees$50022%
- Food & beverage$1,81678%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $1,068 |
| Johnson & Johnson | 33 | $642 |
| Pharmacosmos Therapeutics Inc. | 1 | $115 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Stryker | 1 | $100 |
| AbbVie | 2 | $94 |
| Medtronic(2 entities) | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Myriad Genetic Laboratories, Inc. | 1 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| KCI USA, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $15 |
| TELA Bio, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,316 in reported general payments places this provider in the 35th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 19 | $817 |
| Hydrocortisone | 42 | $724 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $470 |
| Procto-Med HcHydrocortisone | 23 | $271 |
| Neomycin Sulfate | 43 | $232 |
| Metronidazole | 48 | $144 |
| Triamcinolone Acetonide | 35 | $142 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $124 |
| Tramadol Hcl | 20 | $58 |
| Ondansetron Hcl | 24 | $49 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Irving
- Jefferson HurleyIrving$188K
- Jaime MayoralSan Antonio$1.8M
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Eric HaasHouston$317K
- Erik AskenasyHouston$254K
- Christopher de JesusSan Antonio$201K
- Katerina WellsDallas$182K
- Farshid AraghizadehFort Worth$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.